IBDEI0N7 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10599,1,4,0)
 ;;=4^N47.6
 ;;^UTILITY(U,$J,358.3,10599,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,10600,0)
 ;;=N48.1^^68^671^2
 ;;^UTILITY(U,$J,358.3,10600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10600,1,3,0)
 ;;=3^Balanitis
 ;;^UTILITY(U,$J,358.3,10600,1,4,0)
 ;;=4^N48.1
 ;;^UTILITY(U,$J,358.3,10600,2)
 ;;=^12525
 ;;^UTILITY(U,$J,358.3,10601,0)
 ;;=N52.34^^68^671^38
 ;;^UTILITY(U,$J,358.3,10601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10601,1,3,0)
 ;;=3^Erectile Dysfunction Following Simple Prostatectomy
 ;;^UTILITY(U,$J,358.3,10601,1,4,0)
 ;;=4^N52.34
 ;;^UTILITY(U,$J,358.3,10601,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,10602,0)
 ;;=N52.39^^68^671^40
 ;;^UTILITY(U,$J,358.3,10602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10602,1,3,0)
 ;;=3^Erectile Dysfunction Post-Surgical
 ;;^UTILITY(U,$J,358.3,10602,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,10602,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,10603,0)
 ;;=N52.33^^68^671^39
 ;;^UTILITY(U,$J,358.3,10603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10603,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,10603,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,10603,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,10604,0)
 ;;=N52.32^^68^671^36
 ;;^UTILITY(U,$J,358.3,10604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10604,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,10604,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,10604,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,10605,0)
 ;;=N52.31^^68^671^37
 ;;^UTILITY(U,$J,358.3,10605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10605,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,10605,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,10605,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,10606,0)
 ;;=N52.2^^68^671^43
 ;;^UTILITY(U,$J,358.3,10606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10606,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,10606,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,10606,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,10607,0)
 ;;=N52.03^^68^671^34
 ;;^UTILITY(U,$J,358.3,10607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10607,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,10607,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,10607,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,10608,0)
 ;;=N52.02^^68^671^35
 ;;^UTILITY(U,$J,358.3,10608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10608,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,10608,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,10608,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,10609,0)
 ;;=N52.1^^68^671^42
 ;;^UTILITY(U,$J,358.3,10609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10609,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,10609,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,10609,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,10610,0)
 ;;=N52.01^^68^671^41
 ;;^UTILITY(U,$J,358.3,10610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10610,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,10610,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,10610,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,10611,0)
 ;;=N95.2^^68^671^81
 ;;^UTILITY(U,$J,358.3,10611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10611,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,10611,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,10611,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,10612,0)
 ;;=R30.9^^68^671^65
